At Alexion Pharmaceuticals, leadership in HEOR Neurology has been my focus, where I've steered evidence and strategic input for new and existing therapies. My team's dedication to health economics has enabled us to pioneer initiatives that address health equity challenges, particularly for underrepresented communities in rare disease treatment. Among our achievements are developing innovative diversity measures and tackling diagnostic and treatment barriers for people of color.
With a strong foundation in market access strategies from my previous role at EMD Serono, I've successfully shaped the launch and pipeline access for neurology products. The skills honed there, including communication and life sciences acumen, have proven integral to my current responsibilities. My approach is patient-centric, ensuring that the voices of those we serve are embedded in our research and outcomes, which not only advances the science but also aligns with our organizational values and mission.
